| Gene Therapy For Rare Genetic Disorders, Glaxo And Two Italian Groups Form Alliance | ||||
|
|
GlaxoSmithKline, Fondazione San Raffaele and Fondazione Telethon have entered an alliance to develop gene therapies for rare genetic disorders. The therapies use stem cells taken from the patient's own bone marrow...
Διαβάστε ολόκληρο το άρθρο στο Medical News Today
|
